SEI Medical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	449.68	443.98	393.57	320.55	375.73
Other Revenue	-	-	-	-	2.47
Revenue	449.68	443.98	393.57	320.55	378.2
Revenue Growth (YoY)	1.28%	12.81%	22.78%	-15.24%	0.14%
Cost of Revenue	293.41	289.66	277.26	219.11	266.41
Gross Profit	156.26	154.32	116.31	101.44	111.79
Selling, General & Admin	98.75	89.11	86.38	78.17	61.84
Other Operating Expenses	-1.43	-1.36	-	-	25.29
Operating Expenses	97.32	87.75	86.38	78.17	87.13
Operating Income	58.94	66.57	29.93	23.27	24.66
Interest Expense	-2.16	-3.34	-3.29	-2.78	-3.14
Interest & Investment Income	1.69	2.07	0.82	0.04	0.01
Currency Exchange Gain (Loss)	-	-	-	-	-1.42
Other Non Operating Income (Expenses)	-	-	0.01	0.28	-
EBT Excluding Unusual Items	58.47	65.3	27.48	20.81	20.1
Gain (Loss) on Sale of Assets	-	-	0.01	1.77	1.68
Asset Writedown	-	-	-	-	-0.01
Pretax Income	58.47	65.3	27.49	22.59	21.78
Income Tax Expense	11.97	13.07	5.62	4.72	6.34
Net Income	46.5	52.23	21.87	17.86	15.44
Net Income to Common	46.5	52.23	21.87	17.86	15.44
Net Income Growth	-10.97%	138.82%	22.43%	15.73%	-46.39%
Shares Outstanding (Basic)	170	134	120	100	12
Shares Outstanding (Diluted)	170	134	120	100	12
Shares Change (YoY)	26.67%	12.09%	19.48%	735.07%	-
EPS (Basic)	0.27	0.39	0.18	0.18	1.29
EPS (Diluted)	0.27	0.39	0.18	0.18	1.29
EPS Growth	-29.72%	113.05%	2.47%	-86.14%	-46.39%
Free Cash Flow	37.25	39.64	-29.95	34.55	-
Free Cash Flow Per Share	0.22	0.29	-0.25	0.34	-
Dividend Per Share	0.110	0.120	-	41.670	-
Dividend Growth	-8.33%	-	-	-	-
Gross Margin	34.75%	34.76%	29.55%	31.65%	29.56%
Operating Margin	13.11%	14.99%	7.61%	7.26%	6.52%
Profit Margin	10.34%	11.76%	5.56%	5.57%	4.08%
Free Cash Flow Margin	8.28%	8.93%	-7.61%	10.78%	-
EBITDA	71.33	77.39	41.81	36.58	-
EBITDA Margin	15.86%	17.43%	10.62%	11.41%	-
D&A For EBITDA	12.39	10.82	11.87	13.31	-
EBIT	58.94	66.57	29.93	23.27	24.66
EBIT Margin	13.11%	14.99%	7.61%	7.26%	6.52%
Effective Tax Rate	20.47%	20.01%	20.43%	20.91%	29.12%
Revenue as Reported	449.68	443.98	393.57	320.55	379.9
Advertising Expenses	-	-	-	-	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.